Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo

Charlotte Ngô, Carole Nicco, Mahaut Leconte, Christiane Chéreau, Bernard Weill, Frédéric Batteux, Charles Chapron
Fertility and sterility · 2010 · vol. 94(5) , pp. 1632–1638.e1 · doi:10.1016/j.fertnstert.2009.09.031 · PMID:20045515 · W2014021692
article OA: closed CC0 ⤵ 13 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated the antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis both in vitro and in vivo.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents Cell Proliferation Endometriosis Fluorouracil Methotrexate Nitriles Triazoles Uterine Diseases Adult Anastrozole Animals Antineoplastic Agents Antineoplastic Agents Biopsy Case-Control Studies Cell Proliferation Cells, Cultured Cell Survival Cell Survival Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (48)

Cited by (13)

Source provenance

europepmc
last seen: 2026-06-19T06:14:56.452680+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:24.614948+00:00
License: CC0 · commercial use OK